Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
AbGn-268 by AltruBio for Psoriatic Arthritis: Likelihood of Approval
AbGn-268 is under clinical development by AltruBio and currently in Phase I for Psoriatic Arthritis. According to GlobalData, Phase I...
Data Insights
AbGn-268 by AltruBio for Ulcerative Colitis: Likelihood of Approval
AbGn-268 is under clinical development by AltruBio and currently in Phase II for Ulcerative Colitis. According to GlobalData, Phase II...